The protein Nek2, belonging to the NIMA (Never in Mitosis Gene A)-related kinase family, serves as a critical regulator of cell cycle progression and centrosome dynamics. Within the cell cycle, Nek2 plays a pivotal role in mitotic entry and progression by orchestrating centrosome separation and spindle assembly, thereby ensuring accurate chromosome segregation during cell division. Functionally, Nek2 phosphorylates a myriad of substrates involved in centrosome duplication, microtubule organization, and mitotic checkpoint regulation, exerting tight control over key cellular processes crucial for faithful cell division. Dysregulation of Nek2 activity is implicated in various human malignancies, including breast, lung, and prostate cancers, where aberrant Nek2 expression correlates with increased tumor aggressiveness, highlighting its significance as a target in cancer.
Activation of Nek2 is tightly regulated by multiple mechanisms operating at both the transcriptional and post-translational levels. Transcriptional regulation of Nek2 expression is governed by cell cycle-dependent transcription factors and signaling pathways involved in mitotic progression, ensuring peak Nek2 levels coincide with key mitotic events. Post-translational modifications, such as phosphorylation and protein-protein interactions, further fine-tune Nek2 activity during the cell cycle. For instance, phosphorylation by upstream kinases, including Plk1 and Cdk1, primes Nek2 for activation and substrate recognition, facilitating its role in centrosome separation and mitotic spindle assembly. Additionally, binding of regulatory proteins and cofactors modulates Nek2 localization and substrate specificity, dictating its functional output during mitosis. Collectively, elucidating the intricate mechanisms underlying Nek2 activation provides crucial insights into its physiological roles in cell cycle regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, enzymes that can dephosphorylate and inactivate Nek2. By inhibiting these phosphatases, Okadaic Acid can lead to an increase in the phosphorylation and activation of Nek2. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, inhibits PP1 and PP2A. This inhibition can prevent the dephosphorylation of Nek2, thereby maintaining its active, phosphorylated state. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can enhance the activity of PKA. PKA phosphorylates a range of proteins, potentially including those that activate Nek2 or its cofactors. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
This methylxanthine is a non-selective inhibitor of phosphodiesterases, leading to an increase in cAMP levels, which may indirectly activate Nek2 through PKA-dependent phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate proteins that are upstream activators of Nek2 or directly phosphorylate Nek2 itself, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels and potentially activating calcium-dependent kinases that could phosphorylate and activate Nek2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin can activate stress-activated protein kinases, which may include kinases that phosphorylate and activate Nek2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels and possibly activating calcium-dependent proteins that could enhance Nek2 activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid can influence cell cycle progression and differentiation pathways that may involve the activation of kinases capable of phosphorylating Nek2, thereby indirectly enhancing its activity. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic Acid inhibits farnesyl pyrophosphate synthase, leading to disruption of the mevalonate pathway, which could affect prenylation and activation of proteins involved in Nek2 regulation. | ||||||